Variant report
Variant | esv3324203 |
---|---|
Chromosome Location | chr3:21184173-21186721 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:21183893-21184180 | IMR90 | lung: | n/a | chr3:21184052-21184063 chr3:21184051-21184064 |
2 | CEBPB | chr3:21183910-21184219 | K562 | blood: | n/a | chr3:21184052-21184063 chr3:21184051-21184064 |
3 | CEBPB | chr3:21183929-21184180 | HepG2 | liver: | n/a | chr3:21184052-21184063 chr3:21184051-21184064 |
4 | CTCF | chr3:21184551-21184600 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr3:21184557-21184615 | MCF-7 | breast: | n/a | n/a |
6 | MYC | chr3:21184515-21184622 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr3:21184589-21184616 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr3:21185757-21185838 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr3:21184564-21184596 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr3:21184478-21184724 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr3:21184470-21184650 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr3:21186073-21186227 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr3:21184261-21184270 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:21175037..21177371-chr3:21182384..21184259,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221659 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115421469 | chr3:21184181-21184182 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs150842787 | chr3:21184182-21184183 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs551684420 | chr3:21184189-21184190 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs186184458 | chr3:21184226-21184227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192457602 | chr3:21184231-21184232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555024528 | chr3:21184245-21184246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573784053 | chr3:21184250-21184251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537279249 | chr3:21184262-21184263 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs556812031 | chr3:21184264-21184265 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs182569371 | chr3:21184284-21184285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185905405 | chr3:21184290-21184291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190822603 | chr3:21184310-21184311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557261262 | chr3:21184311-21184312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149596502 | chr3:21184380-21184381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60280783 | chr3:21184413-21184414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113769522 | chr3:21184435-21184436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182555699 | chr3:21184442-21184443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527986930 | chr3:21184456-21184457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144337619 | chr3:21184457-21184458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567746835 | chr3:21184486-21184487 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs386659150 | chr3:21184487-21184488 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs565020210 | chr3:21184489-21184490 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs58212710 | chr3:21184496-21184497 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs533203729 | chr3:21184524-21184525 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs34556437 | chr3:21184550-21184551 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs566769992 | chr3:21184556-21184557 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs373506876 | chr3:21184577-21184578 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs527548468 | chr3:21184589-21184590 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs144886229 | chr3:21184627-21184628 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs567237188 | chr3:21184630-21184631 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs35819593 | chr3:21184639-21184640 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs374843001 | chr3:21184644-21184645 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs34547849 | chr3:21184647-21184648 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs112027196 | chr3:21184735-21184736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539230197 | chr3:21184737-21184738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554025599 | chr3:21184745-21184746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs35338631 | chr3:21184753-21184754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs142069315 | chr3:21184772-21184773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187253653 | chr3:21184773-21184774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576052995 | chr3:21184794-21184795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192073305 | chr3:21184824-21184825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140447987 | chr3:21184872-21184873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183176941 | chr3:21184893-21184894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs151152256 | chr3:21184895-21184896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71613652 | chr3:21184897-21184898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs193206296 | chr3:21184899-21184900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113023491 | chr3:21184906-21184907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565081042 | chr3:21184912-21184913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113774876 | chr3:21184918-21184919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185585527 | chr3:21184919-21184920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:21180000-21184600 | Weak transcription | Pancreas | Pancrea |
2 | chr3:21182400-21184600 | Weak transcription | Aorta | Aorta |
3 | chr3:21184600-21184800 | Enhancers | Aorta | Aorta |
4 | chr3:21184600-21184800 | Enhancers | Pancreas | Pancrea |
5 | chr3:21184800-21185200 | Weak transcription | Pancreas | Pancrea |
6 | chr3:21184800-21186600 | Weak transcription | Aorta | Aorta |